These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25296234)

  • 1. Induction therapy in renal transplant recipients: a review.
    Laftavi MR; Sharma R; Feng L; Said M; Pankewycz O
    Immunol Invest; 2014; 43(8):790-806. PubMed ID: 25296234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.
    Sageshima J; Ciancio G; Chen L; Dohi T; El-Hinnawi A; Paloyo S; Gaynor JJ; Mattiazzi A; Guerra G; Kupin W; Roth D; Ruiz P; Burke GW
    Transpl Immunol; 2014 Mar; 30(2-3):88-92. PubMed ID: 24518158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is induction therapy still needed in heart transplantation?
    Aliabadi A; Grömmer M; Zuckermann A
    Curr Opin Organ Transplant; 2011 Oct; 16(5):536-42. PubMed ID: 21836518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
    Stratta RJ; Farney AC; Rogers J; Orlando G
    Expert Rev Clin Immunol; 2014 Jan; 10(1):117-32. PubMed ID: 24236648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trend of induction and maintenance treatment in positive panel-reactive antibody patients: a report on OPTN/UNOS kidney transplant registry data.
    Cai J; Terasaki PI
    Chin Med J (Engl); 2011 Mar; 124(5):649-54. PubMed ID: 21518552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction antibody therapy in kidney transplantation.
    Padiyar A; Augustine JJ; Hricik DE
    Am J Kidney Dis; 2009 Nov; 54(5):935-44. PubMed ID: 19682780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current pharmacotherapeutical options for the prevention of kidney transplant rejection.
    Schaefer SM; Süsal C; Sommerer C; Zeier M; Morath C
    Expert Opin Pharmacother; 2013 Jun; 14(8):1029-41. PubMed ID: 23560807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting long-term graft and patient survival after transplantation.
    Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA
    Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients.
    Casale JP; Taber DJ; Staino C; Boyle K; Covert K; Pilch NA; Mardis C; Meadows HB; Chavin KD; McGillicuddy JW; Baliga PK; Fleming JN
    Pharmacotherapy; 2017 Jun; 37(6):692-699. PubMed ID: 28475248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance immunosuppression.
    Takemoto SK
    Clin Transpl; 2000; ():481-95. PubMed ID: 11512360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
    Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients.
    Lim W; Chadban S; Campbell S; Dent H; Russ G; McDonald S
    Transpl Int; 2010 Dec; 23(12):1207-15. PubMed ID: 20536789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.